CAI — Caris Life Sciences, Inc.
7 mentions in the last 24 hours · 0.03% of all mentions
Why people talked about CAI (2026-11-05)
- Caris Life Sciences reported Q3 2026 EPS of $0.05, beating estimates by 150.0%.
- Revenue reached $275.4M, surpassing the $254.4M estimate by 8.2%.
- The company increased its 2026 revenue guidance following the results.
| GDELT | 3 | news |
| Bluesky | 2 | community |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |